Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-27 @ 4:05 AM
Study NCT ID:
NCT06125834
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2023-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization: